J

Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223

Watchlist Manager
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Watchlist
Price: 29.52 CNY 0.41% Market Closed
Market Cap: ¥29.6B

Jiangsu Yuyue Medical Equipment & Supply Co Ltd
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Jiangsu Yuyue Medical Equipment & Supply Co Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Net Income (Common)
¥1.3B
CAGR 3-Years
-11%
CAGR 5-Years
-7%
CAGR 10-Years
12%
S
Shanghai MicroPort MedBot Group Co Ltd
HKEX:2252
Net Income (Common)
-¥249.7m
CAGR 3-Years
40%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Net Income (Common)
¥820.6m
CAGR 3-Years
32%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Net Income (Common)
¥8.1B
CAGR 3-Years
-5%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Andon Health Co Ltd
SZSE:002432
Net Income (Common)
¥1.9B
CAGR 3-Years
-52%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Net Income (Common)
¥1.3B
CAGR 3-Years
-4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Jiangsu Yuyue Medical Equipment & Supply Co Ltd
Glance View

Market Cap
29.6B CNY
Industry
Health Care

Jiangsu Yuyue Medical Equipment & Supply Co Ltd embodies the dynamic spirit of China's burgeoning healthcare sector. Founded in the heart of China's manufacturing hub, Jiangsu province, this company has steadily carved a niche for itself in the realm of medical equipment and supplies. With an eye for innovation and a sharp focus on quality, Yuyue specializes in the production of respiratory care devices, blood pressure monitors, and other medical diagnostics tools that are essential in both clinical settings and at-home healthcare. The company’s dedication to integrating advanced technology with user-friendly designs has not only propelled its domestic growth but also increased its footprint in international markets. By meticulously ensuring their products meet stringent regulatory standards, Yuyue competently aligns itself with the healthcare industry's rigorous demands. The financial lifeblood of Jiangsu Yuyue lies in its robust sales and distribution networks, which are critical in a sector as diversified and regulation-intensive as medical equipment. Through an extensive distribution network, including direct sales, strategic partnerships, and well-developed online platforms, the company effectively reaches both institutional clients and individual consumers. Additionally, the company leverages economies of scale and in-house expertise to maintain competitive pricing, helping it capture substantial market share. As healthcare needs continue to evolve globally, Yuyue's commitment to research and development positions it to not only meet current demands but also anticipate future trends, ensuring continuous revenue growth and reinforcing its status as a prominent player in the medical equipment industry.

Intrinsic Value
36.19 CNY
Undervaluation 18%
Intrinsic Value
Price ¥29.52
J

See Also

What is Jiangsu Yuyue Medical Equipment & Supply Co Ltd's Net Income (Common)?
Net Income (Common)
1.3B CNY

Based on the financial report for Mar 31, 2026, Jiangsu Yuyue Medical Equipment & Supply Co Ltd's Net Income (Common) amounts to 1.3B CNY.

What is Jiangsu Yuyue Medical Equipment & Supply Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
12%

Over the last year, the Net Income (Common) growth was -27%. The average annual Net Income (Common) growth rates for Jiangsu Yuyue Medical Equipment & Supply Co Ltd have been -11% over the past three years , -7% over the past five years , and 12% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett